Recent findings indicate CRL4-DCAF5 targets methylated proteins for ubiquitin-dependent proteolysis [68] including SOX2 protein which is a master stem cell associated with many different types of cancers and has been proposed as an anticancer target [69,70]. The gene discussed is SOX2; the disease is cancer.